OHTUVAYRE

Serial Number 98494784
Registration 7750645
700

Registration Progress

Application Filed
Apr 11, 2024
Under Examination
Approved for Publication
Feb 18, 2025
Published for Opposition
Feb 18, 2025
Registered
Apr 8, 2025

Professional Deadline Assistance

Important Deadline Approaching

Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-08)
Due: April 08, 2031 (2101 days remaining)

Grace period ends: October 08, 2031

Why Professional Help Matters
  • Ensure all required documents are filed correctly
  • Avoid costly mistakes that could result in abandonment
  • Save time with experienced trademark attorneys
  • Get expert guidance on complex filing requirements
Get Professional Help for This Deadline

Secure connection to Stones Law professional services

Basic Information

Serial Number
98494784
Registration Number
7750645
Filing Date
April 11, 2024
Registration Date
April 8, 2025
Published for Opposition
February 18, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 8, 2025
Registration
Registered
Classes
005 042 044

Rights Holder

Verona Pharma PLC

84
Address
One Central Square
Cardiff, Wales CF101FS
GB

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 700

Ownership History

Verona Pharma PLC

Original Applicant
84
Cardiff, Wales GB

Verona Pharma PLC

Owner at Publication
84
Cardiff, Wales GB

Verona Pharma PLC

Original Registrant
84
Cardiff, Wales GB

Legal Representation

Attorney
John Mueller
USPTO Deadlines
Next Renewal Deadline
Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-08)
Due: April 08, 2031 (2101 days remaining)
Grace period ends: October 08, 2031
Additional renewal deadlines exist. Contact your attorney for complete deadline information.

Professional Deadline Assistance

Your Next Critical Deadline: Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-08)

Deadline Date: April 8, 2031

Days Remaining: 2101 days

Grace Period Ends: October 8, 2031

Priority Level: Critical

Missing this deadline could result in abandonment or cancellation of your trademark registration. Professional assistance ensures proper filing and compliance with USPTO requirements.

Application History

27 events
Date Code Type Description
Apr 8, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 8, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 2, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 5, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 5, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 5, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 5, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 18, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 18, 2025 PUBO A PUBLISHED FOR OPPOSITION
Feb 12, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 29, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2024 ALIE A ASSIGNED TO LIE
Nov 21, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2024 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 21, 2024 CNSL R SUSPENSION LETTER WRITTEN
Aug 21, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED
Aug 21, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 21, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN
Aug 21, 2024 GNSL F LETTER OF SUSPENSION E-MAILED
Aug 21, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 21, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED
Aug 20, 2024 DOCK D ASSIGNED TO EXAMINER
Jul 31, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 11, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma.
Class 042
Scientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma.
Class 044
Medical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma; provision of medical information and services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma.

Additional Information

Design Mark
The mark consists of the literal element "OHTUVAYRE" in black stylized type with a violet semi-wave design going left to right above over the letter "V" and reaching the letter "Y", and an aquamarine wave above over the letter "V" and extending to the letter "E".
Color Claim
The colors black, violet and aquamarine are claimed as a feature of the mark.

Classification

International Classes
005 042 044